At the Interface of Fibrinolysis and Inflammation: The Role of Urokinase-Type Plasminogen Activator in the Leukocyte Extravasation Cascade

Trends in Cardiovascular Medicine

Volumn 22, Issue 7, 2012, Pages 192-196

  Reichel, Christoph A ^a   Kanse, Sandip M ^b   Krombach, Fritz ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ANTIPLASMIN; CATHEPSIN G; CD18 ANTIGEN; FIBRIN; INTERCELLULAR ADHESION MOLECULE 1; LEUKOCYTE ELASTASE; MYELOPEROXIDASE; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; UROKINASE RECEPTOR;

ACUTE DISEASE; ATHEROSCLEROSIS; BASEMENT MEMBRANE; BLOOD VESSEL WALL; CANCER THERAPY; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CLINICAL TRIAL (TOPIC); ENDOTHELIUM CELL; FIBRINOLYSIS; HEART INFARCTION; HUMAN; IMMUNE SYSTEM; INFLAMMATION; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; LUNG INFECTION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; REVIEW;

CELL ADHESION; ENDOTHELIUM, VASCULAR; FIBRINOLYSIS; HUMANS; INFLAMMATION; LEUKOCYTE ROLLING; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84869026527     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2012.07.019     Document Type: Review

References (41)

1. Bixel M.G., Petri B., Khandoga A.G., et al. A CD99-related antigen on endothelial cells mediates neutrophil but not lymphocyte extravasation in vivo. Blood 2007, 109:5327-5336.
2. Chavakis T., May A.E., Preissner K.T., Kanse S.M. Molecular mechanisms of zinc-dependent leukocyte adhesion involving the urokinase receptor and beta2-integrins. Blood 1999, 93:2976-2983.
3. Connolly B.M., Choi E.Y., Gårdsvoll H., et al. Selective abrogation of the uPA-uPAR interaction in vivo reveals a novel role in suppression of fibrin-associated inflammation. Blood 2010, 116:1593-1603.
4. Cozen A.E., Moriwaki H., Kremen M., et al. Macrophage-targeted overexpression of urokinase causes accelerated atherosclerosis, coronary artery occlusions, and premature death. Circulation 2004, 109:2129-2135.
5. Degen J.L., Bugge T.H., Goguen J.D. Fibrin and fibrinolysis in infection and host defense. J Thromb Haemost 2007, 5(Suppl 1):24-31.
6. Deindl E., Ziegelhöffer T., Kanse S.M., et al. Receptor-independent role of the urokinase-type plasminogen activator during arteriogenesis. FASEB J 2003, 17:1174-1176.
7. Del Rosso M., Margheri F., Serratì S., et al. The urokinase receptor system, a key regulator at the intersection between inflammation, immunity, and coagulation. Curr Pharm Des 2011, 17:1924-1943.
8. Farris S.D., Hu J.H., Krishnan R., et al. Mechanisms of urokinase plasminogen activator (uPA)-mediated atherosclerosis: Role of the uPA receptor and S100A8/A9 proteins. J Biol Chem 2011, 286:22665-22677.
9. Gasser O., Schifferli J.A. Activated polymorphonuclear neutrophils disseminate anti-inflammatory microparticles by ectocytosis. Blood 2004, 104:2543-2548.
10. Goldstein L.J. Experience in phase I trials and an upcoming phase II study with uPA inhibitors in metastatic breast cancer. Breast Care (Basel) 2008, 3:25-28.
11. Gueler F., Rong S., Mengel M., et al. Renal urokinase-type plasminogen activator (uPA) receptor but not uPA deficiency strongly attenuates ischemia reperfusion injury and acute kidney allograft rejection. J Immunol 2008, 181:1179-1189.
12. Gyetko M.R., Chen G.H., McDonald R.A., et al. Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans: A murine transgenic model. J Clin Invest 1996, 97:1818-1826.
13. Gyetko M.R., Sud S., Kendall T., et al. Urokinase receptor-deficient mice have impaired neutrophil recruitment in response to pulmonary Pseudomonas aeruginosa infection. J Immunol 2000, 165:1513-1519.
14. Herndon M.E., Stipp C.S., Lander A.D. Interactions of neural glycosaminoglycans and proteoglycans with protein ligands: Assessment of selectivity, heterogeneity and the participation of core proteins in binding. Glycobiology 1999, 9:143-155.
15. Kanse S.M., Parahuleva M., Muhl L., et al. Factor VII-activating protease (FSAP): Vascular functions and role in atherosclerosis. Thromb Haemost 2008, 99:286-289.
16. Kremen M., Krishnan R., Emery I., et al. Plasminogen mediates the atherogenic effects of macrophage-expressed urokinase and accelerates atherosclerosis in apoE-knockout mice. Proc Natl Acad Sci U S A 2008, 105:17109-17114.
17. Ley K., Laudanna C., Cybulsky M.I., Nourshargh S. Getting to the site of inflammation: The leukocyte adhesion cascade updated. Nat Rev Immunol 2007, 7:678-689.
18. May A.E., Kanse S.M., Lund L.R., et al. Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo. J Exp Med 1998, 188:1029-1037.
19. May A.E., Schmidt R., Kanse S.M., et al. Urokinase receptor surface expression regulates monocyte adhesion in acute myocardial infarction. Blood 2002, 100:3611-3617.
20. Minami E., Castellani C., Malchodi L., et al. The role of macrophage-derived urokinase plasminogen activator in myocardial infarct repair: Urokinase attenuates ventricular remodeling. J Mol Cell Cardiol 2010, 49:516-524.
21. Nourshargh S., Hordijk P.L., Sixt M. Breaching multiple barriers: Leukocyte motility through venular walls and the interstitium. Nat Rev Mol Cell Biol 2010, 11:366-378.
22. Phillipson M., Heit B., Colarusso P., et al. Intraluminal crawling of neutrophils to emigration sites: A molecularly distinct process from adhesion in the recruitment cascade. J Exp Med 2006, 203:2569-2575.
23. Plesner T., Ploug M., Ellis V., et al. The receptor for urokinase-type plasminogen activator and urokinase is translocated from two distinct intracellular compartments to the plasma membrane on stimulation of human neutrophils. Blood 1994, 83:808-815.
24. Pluskota E., Soloviev D.A., Plow E.F. Convergence of the adhesive and fibrinolytic systems: Recognition of urokinase by integrin alpha Mbeta 2 as well as by the urokinase receptor regulates cell adhesion and migration. Blood 2003, 101:1582-1590.
25. Proebstl D., Voisin M.B., Woodfin A., et al. Pericytes support neutrophil subendothelial cell crawling and breaching of venular walls in vivo. J Exp Med 2012, 209:1219-1234.
26. Reichel C.A., Lerchenberger M., Uhl B., et al. Plasmin inhibitors prevent leukocyte accumulation and remodeling events in the postischemic microvasculature. PLoS ONE 2011, 6:e17229.
27. Reichel C.A., Puhr-Westerheide D., Zuchtriegel G., et al. C-C motif chemokine CCL3 and canonical neutrophil attractants promote neutrophil extravasation through common and distinct mechanisms. Blood 2012, 120:880-890.
28. Reichel C.A., Rehberg M., Bihari P., et al. Gelatinases mediate neutrophil recruitment in vivo: Evidence for stimulus specificity and a critical role in collagen IV remodeling. J Leukoc Biol 2008, 83:864-874.
29. Reichel C.A., Rehberg M., Lerchenberger M., et al. Ccl2 and Ccl3 mediate neutrophil recruitment via induction of protein synthesis and generation of lipid mediators. Arterioscler Thromb Vasc Biol 2009, 29:1787-1793.
30. Reichel C.A., Uhl B., Lerchenberger M., et al. Urokinase-type plasminogen activator promotes paracellular transmigration of neutrophils via Mac-1, but independently of urokinase-type plasminogen activator receptor. Circulation 2011, 124:1848-1859.
31. Rijneveld A.W., Levi M., Florquin S., et al. Urokinase receptor is necessary for adequate host defense against pneumococcal pneumonia. J Immunol 2002, 168:3507-3511.
32. Rowe R.G., Weiss S.J. Breaching the basement membrane: Who, when and how?. Trends Cell Biol 2008, 18:560-574.
33. Schulte D., Küppers V., Dartsch N., et al. Stabilizing the VE-cadherin-catenin complex blocks leukocyte extravasation and vascular permeability. EMBO J 2011, 30:4157-4170.
34. Sitrin R.G., Todd R.F., Albrecht E., Gyetko M.R. The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes. J Clin Invest 1996, 97:1942-1951.
35. Smith H.W., Marshall C.J. Regulation of cell signalling by uPAR. Nat Rev Mol Cell Biol 2010, 11:23-36.
36. Wang S., Voisin M.B., Larbi K.Y., et al. Venular basement membranes contain specific matrix protein low expression regions that act as exit points for emigrating neutrophils. J Exp Med 2006, 203:1519-1532.
37. Weber C., Noels H. Atherosclerosis: Current pathogenesis and therapeutic options. Nat Med 2011, 17:1410-1422.
38. Wegmann F., Petri B., Khandoga A.G., et al. ESAM supports neutrophil extravasation, activation of Rho, and VEGF-induced vascular permeability. J Exp Med 2006, 203:1671-1677.
39. Woodfin A., Reichel C.A., Khandoga A., et al. JAM-A mediates neutrophil transmigration in a stimulus-specific manner in vivo: Evidence for sequential roles for JAM-A and PECAM-1 in neutrophil transmigration. Blood 2007, 110:1848-1856.
40. Woodfin A., Voisin M.B., Beyrau M., et al. The junctional adhesion molecule JAM-C regulates polarized transendothelial migration of neutrophils in vivo. Nat Immunol 2011, 12:761-769.
41. Zarbock A., Ley K., McEver R.P., Hidalgo A. Leukocyte ligands for endothelial selectins: Specialized glycoconjugates that mediate rolling and signaling under flow. Blood 2011, 118:6743-6751.